جست‌وجوی استاد و پژوهشگر

David Waldeckمشاهده پروفایل

استاد

• Chiral-Induced Spin Selectivity
• Electrochemistry
• Spectroscopy
• +۳ مورد دیگر

David Waldeck is a Distinguished Professor in the Department of Chemistry at the University of Pittsburgh's Dietrich School of Arts and Sciences. His research focuses on the Chiral-Induced Spin Selectivity (CISS) effect, using spectroscopy, electrochemistry, and microscopy to investigate spin-filtering in electron currents and its technological applications. He leads the Waldeck Lab, which explores chiral nanomaterials, spin-polarized electrochemistry, and the role of homochirality in biological processes. His research interests span chiral-induced spin phenomena, nanomaterials design, electrochemical processes, and biological electron transfer. Recent work examines how chiral symmetry in nanostructures enables efficient charge/spin transport and the implications of spin polarization for enantioselective interactions in biochemistry. Waldeck's publications demonstrate strong interdisciplinary focus, with articles frequently appearing in high-impact chemistry, physics, and materials science journals. His recent work reveals a trend toward practical applications of spin effects in energy conversion, catalysis, and biomedical technologies. Morley Award of the Cleveland Section of the ACS, 2024 Fellow of the American Chemical Society, 2020 ISE Bioelectrochemistry Prize, 2018 AAAS Fellow, 2017 ACS-WCC Award for Encouraging Women in Chemistry, 2016 ACS Pittsburgh Award, 2014 Fellow of the American Physical Society, 2005 Belkin Visiting Professor, Weizmann Institute 1998-1999 Chancellor's Distinguished Research Award, University of Pittsburgh, 1994 The Waldeck Lab actively collaborates with international researchers and accepts graduate students to work on fundamental and applied aspects of spin-dependent phenomena.

Jamie Alanمشاهده پروفایل

دانشیار

• Neuroscience
• Aging
• Neurodegenerative Diseases
• +۳ مورد دیگر

Dr. Jamie Alan is an Associate Professor in the Department of Pharmacology & Toxicology at Michigan State University (MSU), affiliated with the College of Human Medicine. Her academic background includes a PharmD from Ohio Northern University (1999–2005), a PhD in Pharmacology from the University of North Carolina at Chapel Hill (2005–2010), and a postdoctoral fellowship in Molecular Biosciences at the University of Kansas (2010–2013). She joined MSU in 2018 as a fixed-term Associate Professor. Her research focuses on Neuroscience and Aging , with emphasis on neurodegenerative diseases (e.g., Alzheimer’s), cancer biology, and the metabolic pathways of polyunsaturated fatty acids. She develops methods for studying oxylipins and employs Caenorhabditis elegans as a model system to investigate Rho GTPase signaling in axon guidance and cancer mechanisms. Dr. Alan’s recent work includes a NIH-funded project ( IMPACT TEAM ) addressing addiction medicine education for medical students and another studying oxylipins in neurodegeneration. She teaches graduate courses on cellular pharmacology and drug-tissue interactions. Her lab contributes to understanding how pharmacological agents and metabolic processes influence disease progression. Funding : National Institute on Drug Abuse (IMPACT TEAM), National Institute on Aging (Oxylipins study). Teaching : PHM 802 (Cellular/Molecular Pharmacology) and PHM 819 (Drug-Tissue Interactions). Her publications span neurodegeneration mechanisms, cancer cell signaling, and drug interactions, reflecting her interdisciplinary approach to pharmacology and toxicology.

• Analytical Chemistry
• Mass Spectrometry
• Bioanalysis
• +۳ مورد دیگر

Prof. Dr. N.C. van de Merbel is an Honorary Professor in Industrial Bioanalysis at the University of Groningen's Faculty of Science and Engineering, affiliated with the Analytical Biochemistry department within the Groningen Research Institute of Pharmacy. He also serves as Scientific Director at PRA International's bioanalytical laboratory. His research focuses on mass spectrometry, liquid chromatography, and regulated bioanalysis, with expertise in developing advanced analytical methods for pharmaceutical and biomedical applications. His work spans bioanalysis of therapeutic proteins, drug metabolism, and biomarker detection, utilizing cutting-edge techniques like LC-MS/MS. Recent studies include investigations into hormone regulation (e.g., SHBG and growth hormone isoforms), protein stability (e.g., trastuzumab and pertuzumab), and antibody-drug interactions. His contributions bridge fundamental research and clinical/industrial applications, emphasizing method development for accurate quantification and characterization of biomolecules. Prof. van de Merbel collaborates extensively in drug development and regulatory science, addressing challenges in bioanalytical methodologies. His lab supports preclinical and clinical studies, ensuring robust analytical platforms for biopharmaceuticals and biomarkers.

Roberto Barrero Gumielمشاهده پروفایل

دانشیار

• Bioinformatics
• Genomics
• Plant Virology
• +۳ مورد دیگر

Associate Professor Roberto Barrero Gumiel is an academic at Queensland University of Technology (QUT), leading the eResearch-Bioinformatics team since 2019. He holds a PhD from the University of Tokyo (2002) and has held prior positions including Assistant Professor at the National Institute of Genetics (Japan, 2004–2006) and Bioinformatics roles at Murdoch University (2006–2018). His research focuses on leveraging genomics and scalable bioinformatics workflows to enhance Australia's biosecurity, particularly in plant virus/viroid diagnostics for imported horticultural commodities. Key research interests include phytopathogen detection, agricultural biosecurity, and the application of next-generation sequencing technologies. Collaborations with the Department of Agriculture, Fisheries and Forestry aim to accelerate phytosanitary testing, supporting Australia's Agriculture 2030 vision. His team developed tools like GA-VirReport for rapid plant pathogen screening. Publications span bioinformatics methodologies, plant virology, and diagnostic tool development. Notable recent work includes miRNA biomarker studies for oral and oropharyngeal cancers, and proteomics-based high-throughput workflows. His contributions align with improving food security and advancing genomic technologies in agricultural and medical contexts.

Daniela Barileمشاهده پروفایل

استاد

• Food Science
• Analytical Chemistry
• Functional Glycomics
• +۳ مورد دیگر

Daniela Barile is a Professor in the Department of Food Science and Technology at the University of California, Davis. Her research focuses on milk functional glycomics, combining analytical chemistry, engineering, and biological approaches to characterize bioactive food components. She holds a Ph.D. and M.S. in Food Science and Chemistry from the University of Piemonte Orientale, Italy. Key areas of expertise include mass spectrometry-based glycomics, separation technologies for food components, and prebiotic oligosaccharide development. Awards include the 2020 UC Davis Chancellor’s Innovation Award (Innovator of the Year), 2017 Chancellor’s Fellow, and 2014 Dean’s Team Award. Her work spans food waste valorization, dairy and plant-based product development, and gut microbiome interactions. She collaborates with the Milk Process Research Lab to scale-up bioactive fractionation processes and has pioneered methods for isolating health-promoting compounds from colostrum, grape pomace, and legume byproducts. Research themes include: 1) Discovery of bioactive carbohydrates/peptides via advanced analytics; 2) Membrane filtration and enzymatic strategies for compound isolation; 3) Prebiotic functionality and metabolic impacts. Recent projects explore Thai plant-based milk alternatives, engineered plant production of human milk oligosaccharides, and functional characterization of almond and chickpea proteins. Her lab integrates glycomics, peptidomics, and metabolomics with food processing innovations, aiming to translate discoveries into functional food ingredients. Current efforts emphasize sustainable utilization of agricultural byproducts and improving nutritional profiles of dairy and plant-based products.

• Nutrition
• Biochemistry
• Flavanols and Procyanidins
• +۳ مورد دیگر

Javier Ottaviani, Ph.D., is an Adjunct Professor at the University of California, Davis, Department of Nutrition, and Director of the Core Laboratory of Mars Edge, part of Mars, Incorporated. He holds a BS/MS and Ph.D. in Biochemistry from the University of Buenos Aires, Argentina. His research focuses on translating innovations in diet and nutrition for health optimization. Key interests include the nutritional impact of flavanols, procyanidins, and bioactive compounds, alongside leveraging sensors and personalized devices for tailored nutrition. Current projects address flavanol metabolism, biomarker development, and dietary intervention studies. Selected publications highlight his work on flavanols’ cognitive benefits, cardiovascular effects, and methodological advancements in biomarker analysis. Ottaviani collaborates on large-scale studies like COSMOS, examining cocoa and multivitamin impacts on health. His lab, the Cocoa Flavanol Science Hub, drives interdisciplinary research in dietary bioactives and personalized nutrition. While no formal awards are listed, his contributions to nutritional science through high-impact studies underscore his expertise. His role at Mars Edge integrates academic and industry research to advance nutritional strategies for public health.

M. Leandro Heienمشاهده پروفایل

دانشیار

• Bioanalytical Chemistry
• Chemical Biology
• Neurotransmitter Measurement
• +۶ مورد دیگر

Dr. M. Leandro Heien is an Associate Professor in the Department of Chemistry and Biochemistry at the University of Arizona, part of the College of Science. His research focuses on developing novel measurement platforms for studying neurotransmitters like dopamine and serotonin, with applications in neuropsychiatric disorders. He holds a B.S. from Truman State University (2000), a Ph.D. from the University of North Carolina at Chapel Hill (2005), and completed postdoctoral research at the University of Illinois at Urbana-Champaign (2005–2007) and Penn State University (2007–2010). Research Interests: The Heien Lab employs electrochemical and mass spectrometric techniques to study real-time neurotransmitter dynamics in vivo. Key areas include dopamine release mechanisms, neuropeptide signaling in mood regulation, and instrument development for precision measurement. Their work bridges analytical chemistry and neuroscience, with implications for addiction and mental health therapies. Advising & Lab: The lab has a strong track record, with a 100% PhD graduation rate (n=11) and an average PhD duration of ~5 years. Current students include Andrea Hamilton, Nathan Weintraub, and Chidiebere Ogbu, while notable alumni include Dr. Blake Seaton and Dr. Chenxi Liu. The lab actively explores software development for data analysis and drug stability studies. Lab Mission: The Heien Lab aims to advance Measurement Science, emphasizing interdisciplinary collaboration between chemistry, neuroscience, and clinical applications. Their work seeks to decode neural communication pathways and translate findings into therapeutic strategies.

• Organic Chemistry
• Medicinal Chemistry
• Drug Discovery
• +۳ مورد دیگر

Professor Wei Wang is a faculty member in the Department of Pharmacology and Toxicology at the University of Arizona's College of Pharmacy. His research focuses on advancing drug discovery through innovative organic and medicinal chemistry approaches, with particular emphasis on anticancer agents, senolytic therapies, and bioorthogonal chemistry. He is affiliated with the Skaggs Pharmaceutical Sciences Center and leads projects in drug design, photocatalytic reactions, and targeted drug delivery systems. Dr. Wang holds a PhD in Chemistry from North Carolina State University (2000), an MS in Organic Chemistry from Shanghai Institute of Materia Medica (1993), and a BS in Chemistry from Nanjing Normal University (1988). His postdoctoral training was conducted at the University of Arizona (2000). His research interests span: Design of novel anticancer agents via photoredox catalysis Development of senolytic prodrugs targeting cellular senescence Creation of bioorthogonal probes for in vivo imaging and drug delivery Development of deuterated compounds for metabolic stability Exploration of photocatalytic systems for energy applications Recent work highlights include discovering selenium-based anticancer agents, developing galacto-modified PROTACs for cancer therapy, and creating fluorescent probes for formaldehyde detection. His research integrates organic synthesis, medicinal chemistry, and nanotechnology to address unmet clinical needs in oncology and aging-related diseases. Dr. Wang’s lab collaborates extensively with other departments at the UA Health Sciences and the Phoenix Biomedical Campus. His work is supported by grants focused on drug discovery platforms and translational research initiatives.

• Bioanalytical Chemistry
• Bioorganic Chemistry
• Chemical Biology
• +۵ مورد دیگر

Indraneel Ghosh is a Professor in the Department of Chemistry & Biochemistry at the University of Arizona. He holds the Emily & Homer Weed Endowed Chair and co-founded Luceome Biotechnologies. His research focuses on bioorganic chemistry, chemical biology, and protein engineering, with expertise in biosensor development and protein kinase modulation. Education: B.S. in Chemistry from Hobart College (1992), Ph.D. in Chemistry from Purdue University (1998), postdoctoral training at Yale University (1998-2001). Research interests include designing protein therapeutics, biosensors, and tools for studying epigenetic regulation. Notable contributions include SEER (Sequence-Enabled Reassembly) systems for DNA detection and split-protein approaches for kinase/phosphatase control. Key awards: NIH Directors Pioneer Award, NSF CAREER Award, and recognition for teaching excellence. Active in grant-funded research, including NIH R01 and NSF projects. Over 60 peer-reviewed publications and multiple patents, with a focus on drug discovery, protein engineering, and biotechnological applications.

Peter Rentzepisمشاهده پروفایل

استاد

• Lasers and Applications
• Ultrafast Spectroscopy
• Biomedical Engineering
• +۴ مورد دیگر

Peter Rentzepis is a Professor in the Department of Electrical and Computer Engineering at Texas A&M University, holding the Texas Instruments (TI) Chair. He is a member of the National Academy of Science and affiliated with the Biomedical Engineering program. His research focuses on lasers and their applications in science and technology, including ultrafast spectroscopy, biomedical diagnostics, and material characterization. He holds an M.S. from Denison University and a Ph.D. from the University of Cambridge. Education: Ph.D., University of Cambridge B.S., Denison University His research interests span laser-induced structural dynamics, photonic devices, and bioanalytical systems. Notable contributions include developing cellphone-based Raman spectrometers for pathogen detection and ultrafast X-ray diffraction techniques for material studies. He has received prestigious awards such as the Irving Langmuir Award in Chemical Physics and honorary doctorates from multiple institutions. Recent publications highlight advancements in ultrafast magneto-optical dynamics, bacterial inactivation mechanisms, and low-cost UV microscopy. His work bridges engineering, physics, and biology, addressing challenges in healthcare and materials science. Awards: Member, National Academy of Science Irving Langmuir Award (American Physical Society) Peter Debye Award (American Chemical Society) Multiple honorary doctorates Professor Rentzepis collaborates with interdisciplinary teams, leveraging his expertise to innovate in optical instrumentation and biomedical applications. His research group develops practical solutions for real-time pathogen detection and advanced material characterization.

• Microscopy and Microanalysis
• Advanced Materials
• Thin Film Coatings
• +۴ مورد دیگر

Professor Dougal McCulloch is a Professor and Director of the Microscopy & Microanalysis Facility at RMIT University's Research & Innovation department, based at the City Campus Australia. His research focuses on advanced materials characterization, including microscopy techniques, thin film coatings, and the study of carbonaceous and disordered solids. He leads projects on novel carbon phases under extreme conditions, corrosion-resistant coatings for aerospace alloys, and neuromorphic signal processing. McCulloch coordinates third-year Applied Physics and teaches first-year Life Science Service Physics. He supervises PhD and Masters students in areas like quantum correlation microscopy and carbon material analysis. His work bridges materials science and applied physics, emphasizing experimental and analytical methods. He collaborates on high-pressure synthesis and structural analysis of materials, contributing to both fundamental science and aerospace engineering applications. Research interests include electron microscopy innovations, advanced thin films for industrial applications, and the electronic structure of solids. Projects involve developing environmentally friendly coatings and exploring nanostructured carbons formed under shear or pressure. McCulloch's facility supports interdisciplinary research with cutting-edge microscopy tools. Teaching responsibilities include coordinating applied physics modules and directing the Microscopy Facility, integrating research and education. Supervision focuses on experimental projects at the intersection of materials science and physics. He actively publishes on carbon phase transformations, memristor technologies, and high-pressure material synthesis, reflecting his commitment to advancing analytical and applied materials research.

Yi Xiaoمشاهده پروفایل

استاد

• Analytical Chemistry
• Biosensors
• Aptamer-Based Technologies
• +۳ مورد دیگر

Yi Xiao is a Professor and the LORD Corporation Distinguished Scholar in the Department of Chemistry at North Carolina State University. She joined NC State in 2021 and holds the title of University Faculty Scholar. Her research focuses on developing aptamer-based biosensors and biotechnologies at the intersection of chemistry, biochemistry, and molecular biology. Her lab specializes in aptamer selection techniques, sensor platforms for small-molecule detection, and applications in forensic science, toxicology, and medical diagnostics. Dr. Xiao earned her B.S. (1994), M.S. (1997), and Ph.D. (2000) in Analytical Chemistry from Northwest University and Nanjing University, both in P.R. China. She has secured over $3 million in grants from NIH, NSF, NIJ, USDA, and industry partners. Her work emphasizes real-world problem-solving through simple, elegant solutions, such as rapid drug detection in bodily fluids, environmental monitoring of toxic metals, and disease diagnosis via portable sensors. Her lab collaborates with researchers across NC State (Biomedical Engineering, Wilson College of Textiles, Statistics), UNC-Chapel Hill, Columbia University, and others. The lab currently includes two postdocs, six Ph.D. students, and seven undergraduates, with two provisional patents filed. Key research themes include aptamer specificity optimization, high-throughput sequencing for SELEX processes, and nuclease-assisted aptamer engineering. Dr. Xiao’s scientific awards include the LORD Corporation Distinguished Scholar designation and University Faculty Scholar recognition. Her contributions span innovations in aptamer-based sensing, including colorimetric assays, electrochemical platforms, and multiplex detection systems for fentanyl, opioids, and synthetic cannabinoids.

Claudia Steinemمشاهده پروفایل

استاد

• Biomolecular Chemistry
• Membrane Biology
• Bioanalytics
• +۴ مورد دیگر

Claudia Steinem is a Full Professor of Biomolecular Chemistry at the University of Göttingen, affiliated with the Institute for Organic and Biomolecular Chemistry. She holds additional roles as an MPG Fellow at the Max-Planck Institute for Dynamics and Self-Organization and a Matter to Life Fellow. Her research focuses on artificial membrane systems, membrane fusion/fission processes, and peptide/protein interactions with lipid membranes. She has pioneered techniques like pore-spanning membranes to study biochemical mechanisms under controlled conditions. Education: Studies in Biology and Chemistry (Diploma in Chemistry, 1994) – University of Münster Doctorate in Chemistry (1997) – University of Münster Habilitation in Biochemistry (2001) – University of Münster Associate Professor at University of Regensburg (2001–2006) Research Interests: Development of artificial membrane platforms to investigate quantitative biochemical processes, including channel-forming peptides (e.g., lugdunin), membrane-cytoskeleton interactions, and fusion/fission dynamics. Recent work explores SNARE-mediated fusion, actomyosin contractility, and lipid domain behavior under constrained geometries. Awards & Fellowships: MPG Fellow (2017–present) Matter to Life Fellow (2018–present) Co-Speaker of the MBExC Cluster (2019–present) Labs & Collaborations: Leads a multidisciplinary group combining organic chemistry, biophysics, and cell biology. Collaborates with the Max Planck Institute and maintains affiliations with the GGNB Graduate School programs in biomolecules and complex systems.

Brendan Griffinمشاهده پروفایل

استاد

• Drug Delivery Systems
• Lipid-Based Formulations
• Nanoparticulate Drug Systems
• +۳ مورد دیگر

Brendan Griffin is a Professor in Pharmaceutics at the University of College Cork (UCC) School of Pharmacy. He holds a BSc. Pharm. and PhD from Trinity College Dublin (TCD) and has extensive industry experience with Élan and Servier. As Course Director of the MSc in Pharmaceutical Technology and Quality Systems, he focuses on training pharmaceutical professionals to become Qualified Persons (QP). His research centers on optimized drug delivery systems, including lipid-based formulations, nanoparticulate systems, and targeted delivery to the brain and intestinal lymphatics. He leads the InPharma EU grant, an Industrial Doctorate program aiming to eliminate animal testing in formulation development by integrating computational and in vitro tools. His work emphasizes collaboration with industry and preclinical models like pigs to predict oral drug absorption and food effects. Education: BSc. Pharm. (TCD), PhD in Pharmaceutics (TCD). Research Interests: Lipid-based formulations for solubility enhancement and bioavailability Nanoparticulate drug delivery systems Targeted delivery mechanisms Computational models for drug development Regulatory science and quality-by-design approaches Pharmaceutical education and training InPharma Project: This EU Horizon 2020 initiative replaces animal testing with predictive in vitro and computational tools, linking drug discovery to clinical trial modeling. Key focus areas include end-to-end drug development and model-based design. Grants & Collaborations: Coordinates InPharma consortium involving academia and industry partners to advance drug formulation science. Labs/Teams: Associated with APC Microbiome Ireland and the School of Pharmacy’s Pharmaceutics division, focusing on interdisciplinary research in drug delivery and biopharmaceutics.

• Metabolomics
• Analytical Chemistry
• Bioanalytical Chemistry
• +۵ مورد دیگر

Mikael Engskog is a Lecturer at the Department of Medicinal Chemistry; Analytical Pharmaceutical Chemistry at Uppsala University. His research focuses on metabolomics using NMR and mass spectrometry, emphasizing sample preparation and method development. He holds a magisterexam in Biomolecular Chemistry from Södertörn University College and a PhD from Karolinska Institutet, where his thesis involved structural characterization of Haemophilus influenzae lipopolysaccharides. Engskog has extensive experience in analytical chemistry techniques including NMR (1H, 13C, 31P), mass spectrometry (GC-MS, ESI-MS), chromatography (HPLC, UPLC), and molecular biology methods (PCR, Western blotting). His research interests span metabolomics applications in cancer, neurodegeneration, and toxicology, with notable contributions to metabolic profiling of cancer cell lines, radiation response mechanisms, and ototoxicity studies. Collaborations include work with Oxford University and Karolinska Institutet on bacterial glycobiology. Engskog’s technical expertise includes method validation, adduct formation analysis, and metabolite selectivity evaluation. His recent work addresses systemic metabolic changes in disease models, leveraging advanced analytical platforms for biomarker discovery. Publications highlight interdisciplinary projects such as microglial inflammation studies, hydrogen gas therapy for hearing loss, and glutamine dependency in tumors. Engskog’s work emphasizes high data quality in LC-MS and NMR profiling, with methodological innovations like the co-feature ratio for chromatographic selectivity assessment. His lab contributes to both fundamental analytical chemistry and translational studies in disease mechanisms.